Xiaojing Gao
@SynBioGaoLab
Followers
3K
Following
472
Media
2
Statuses
362
Assistant Professor @ Stanford ChemE synthetic biology, biomolecular engineering https://t.co/KAajKt7YdT
Stanford, CA
Joined June 2019
RT @GraceKC: Can we use RNA to insert kilobases of DNA into the human genome, opening up a new way to engineer cells or treat disease?. Exc….
0
61
0
RT @ScienceKyle: 🚨 New Preprint 🚨 .A continuous landscape of signaling encodes a corresponding landscape of CAR T cell phenotype. How can w….
0
55
0
RT @ElowitzLab: Synthetic biology could enable new types of programmable therapeutics. Our new preprint introduces synthetic protein circui….
0
78
0
The machine-guided humanization paper is out after peer review! Key contributions from current and previous international students on visas, representing 5+ countries.
So we beat on. Gene/cell therapies often use proteins that could be recognized/rejected as non-self by our immune system. We combine algorithms to build proteins that are therapeutically relevant and can masquerade as our own parts
0
4
27
RT @calinplesa: New preprint! We carried out the largest complementation and inhibition study for diverse homologs in a single protein fami….
0
13
0
RT @stergachislab: Plasmid-based reporter assays are the bedrock of regulatory genomics. But a basic question has gone unanswered for decad….
0
82
0
RT @AASForumOrg: AASF cautions harm to US talent pipeline from new State Dept policy to aggressively revoke visas for Chinese students, inc….
0
12
0
RT @LomvardasLab: Awesome new paper from Shan Za and @ColumbiaBiochem and systems biology colleague Chaolin Zhang @….
0
8
0
RT @ChEnected: Did you miss the abstract submission deadline for #mSBW2025? We have a few spots open, but you must submit by tonight (May 1….
0
2
0
RT @ChengHuangThu: Our new paper is just online. Congratulations to Junjie and the team.Super Recombinator (SuRe): An in vivo recombination….
0
2
0
Editing 14 genes is no small feat, but I am not seeing enough evidence that "it is a dire wolf". Our community needs to communicate better to the public, now mor than ever, and imo that includes not exaggerating what we can deliver.
TIME's new cover: The dire wolf is back after over 10,000 years. Here's what that means for other extinct species
14
32
368
RT @LucksLab: Congrats to @ChappellLab (a @NUSynBio alumni!) on their latest in @NatureBiotech :. Amazing RNA engi….
0
4
0
Apparently the original post was gone. Here's what the post is referring to:
0
1
2
More importantly, for diseases that have to be addressed using nucleic acid therapies, such as some recalcitrant cancers, RNA offers the safer option than the more conventional DNA vectors, because RNA is less likely to leave permanent marks in the patients' cells.
0
0
5
If I might clumsily point out the economic impact: our project germinated from @impetusgrants and an NIH trailblazer grant that add up to ~$0.5M, and now our company supports a dozen employees.
1
1
10
Grateful for the recognition and for my team's dedication. When I wrote it in Oct, I didn't anticipate that the title would feel defiant. The original draft even had a now quaint reference to "the comparative comfort of the ivory tower", which was wisely removed.
8
3
67
RT @santimillef: Out today! LIDAR, a new class of synthetic receptors expanding the cell engineering toolbox. We demonstrate orthogonal sen….
0
6
0